Your browser doesn't support javascript.
loading
False biomarker discovery due to reactivity of a commercial ELISA for CUZD1 with cancer antigen CA125.
Prassas, Ioannis; Brinc, Davor; Farkona, Sofia; Leung, Felix; Dimitromanolakis, Apostolos; Chrystoja, Caitlin C; Brand, Randall; Kulasingam, Vathany; Blasutig, Ivan M; Diamandis, Eleftherios P.
Affiliation
  • Prassas I; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada;
Clin Chem ; 60(2): 381-8, 2014 Feb.
Article in En | MEDLINE | ID: mdl-24097894

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Enzyme-Linked Immunosorbent Assay / CA-125 Antigen / Carcinoma, Pancreatic Ductal / Membrane Proteins Type of study: Diagnostic_studies / Prognostic_studies / Screening_studies Limits: Humans Language: En Journal: Clin Chem Journal subject: QUIMICA CLINICA Year: 2014 Document type: Article Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Enzyme-Linked Immunosorbent Assay / CA-125 Antigen / Carcinoma, Pancreatic Ductal / Membrane Proteins Type of study: Diagnostic_studies / Prognostic_studies / Screening_studies Limits: Humans Language: En Journal: Clin Chem Journal subject: QUIMICA CLINICA Year: 2014 Document type: Article Country of publication: Reino Unido